Latest News and Press Releases
Want to stay updated on the latest news?
-
SOCIETE GENERALE SFH: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2025 Regulated Information Paris, 31 March 2026 Societe Generale SFH (“Société de Financement de l’Habitat”, Home Loans SFH)...
-
SOCIÉTÉ GÉNÉRALE SFH : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Information réglementée Paris, le 31 mars 2026 Société Générale SFH (Société de Financement de l’Habitat) informe le...
-
SOCIETE GENERALE SCF: AVAILABILITY OF THE ANNUAL FINANCIAL REPORT FOR 2025 Regulated Information Paris, 31 March 2026 Societe Generale SCF (“Société de Crédit Foncier”, Public Sector Loans) hereby...
-
SOCIÉTÉ GÉNÉRALE SCF : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Information réglementée Paris, le 31 mars 2026 Société Générale SCF (Société de Crédit Foncier) informe le public que son...
-
SAN FRANCISCO, March 31, 2026 (GLOBE NEWSWIRE) -- Digits, the world’s first AI-native accounting platform, today launched the Digits app for iPhone and iPad, enabling business owners to run their...
-
VelocityEHS names Cory Gendron CRO to drive global growth, advancing AI-powered EHS solutions and expanding the Accelerate Platform for safer workplaces.
-
Rocket Doctor appoints two senior leaders, bringing extensive backgrounds across digital health, AI-driven clinical product development, and scalable enterprise platformsDirector of Product, Dr....
-
IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2...
-
Bethesda, MD, March 31, 2026 (GLOBE NEWSWIRE) -- The cybersecurity workforce has a bigger problem than headcount: the people already on the team don't have the skills to match today's threats. That...
-
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved...